| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/27/2001 | WO2001070733A2 Di-substituted iminoheterocyclic compounds |
| 09/27/2001 | WO2001070732A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070731A1 Decahydro-isoquinolines |
| 09/27/2001 | WO2001070730A1 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds |
| 09/27/2001 | WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 09/27/2001 | WO2001070728A1 2-[nitrogen-heterocyclic]pyrimidone derivatives |
| 09/27/2001 | WO2001070727A1 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives |
| 09/27/2001 | WO2001070726A1 Aminophenyl pyrimidone derivatives |
| 09/27/2001 | WO2001070725A1 2-[indanylamino]pyrimidone and 2-[tetrahydronaphthalenylamino]pyrimidone derivatives |
| 09/27/2001 | WO2001070708A1 Substituted piperidines as melanocortin receptor agonists |
| 09/27/2001 | WO2001070700A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/27/2001 | WO2001070691A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070685A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | WO2001070684A2 Peptidomimetic ligands for cellular receptors and ion channels |
| 09/27/2001 | WO2001070683A2 3-substituted-4-pyrimidone derivatives |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070671A2 Insecticidal anthranilamides |
| 09/27/2001 | WO2001070669A2 Process for forming an amide bond |
| 09/27/2001 | WO2001070232A1 Protease inhibitors |
| 09/27/2001 | WO2001070230A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 09/27/2001 | WO2001070229A1 Thrombin inhibitors |
| 09/27/2001 | WO2001070228A1 Antagonists of gonadotropin releasing hormone |
| 09/27/2001 | WO2001070223A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma |
| 09/27/2001 | WO2001070222A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 09/27/2001 | WO2001062705A8 Aminoalcohol derivatives |
| 09/27/2001 | WO2001062234A8 Dosing regimen |
| 09/27/2001 | WO2001034632A3 Aliphatic hydroxy substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents |
| 09/27/2001 | WO2001032663A3 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/27/2001 | WO2001004115A3 Novel process for synthesis of heteroaryl-substituted urea compounds |
| 09/27/2001 | WO2000061541A3 Pharmaceutical compounds |
| 09/27/2001 | WO2000061537A3 Pharmaceutical compounds |
| 09/27/2001 | US20010025108 Thrombosis diseases |
| 09/27/2001 | US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives |
| 09/27/2001 | US20010025049 Heterocyclic compounds and their therapeutic use |
| 09/27/2001 | US20010025047 Nitrogen containing bicyclic heteroaromatic compound containing sulfonamide and hydroxyamide groups, useful in treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, bone disease and HIV infections |
| 09/27/2001 | DE10014761A1 New N-halophenyl-pyrazole and N-pyridyl-pyrazole derivatives useful as broad spectrum, selective herbicides |
| 09/27/2001 | DE10014006A1 New heterocyclic acylsulfimide derivatives, useful as insecticides, acaricides and nematocides for plant protection or in veterinary medicine |
| 09/27/2001 | DE10013712A1 Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung Nicotine salts with improved taste, process for their preparation and their use |
| 09/27/2001 | CA2723664A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | CA2404206A1 Protease inhibitors |
| 09/27/2001 | CA2404131A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2404094A1 Process for forming an amide bond |
| 09/27/2001 | CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2403558A1 Thrombin inhibitors |
| 09/27/2001 | CA2402564A1 Heteroaromatic compounds having two-photon absorption activity |
| 09/27/2001 | CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha. |
| 09/27/2001 | CA2400637A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma |
| 09/27/2001 | CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | CA2399985A1 Compounds with 5-ht activity useful for controlling visual field loss |
| 09/27/2001 | CA2391316A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | CA2364268A1 Di-substituted iminoheterocyclic compounds |
| 09/26/2001 | EP1136493A1 2-(Thienopyridinyl)pyrimidone, 2-(furopyridinyl)pyrimidone 2-(isoquinolinyl)pyrimidone, 2-(pyridoindolyl)pyrimidone and 2-(benzofuropyridinyl)pyrimidone derivatives |
| 09/26/2001 | EP1136491A1 2-[(Heteroaryl)alkylamino]pyrimidone derivatives |
| 09/26/2001 | EP1136489A1 2-[Piperidin-1-yl]pyrimidone derivatives |
| 09/26/2001 | EP1136488A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities |
| 09/26/2001 | EP1136487A1 Nicotine salts with improved taste, process for their preparation and use thereof as smoking cessation agents |
| 09/26/2001 | EP1136486A1 2-[Indanylamino]pyrimidone and 2-[tetrahydronaphthalenylamino]pyrimidone derivatives |
| 09/26/2001 | EP1136485A1 Aminophenyl pyrimidone derivatives |
| 09/26/2001 | EP1136484A1 2-(Arylalkylamino)pyrimidone derivatives |
| 09/26/2001 | EP1136483A1 2-[Piperazinyl]pyrimidone derivatives |
| 09/26/2001 | EP1136482A1 2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors |
| 09/26/2001 | EP1136474A1 1-Acetyl-5-bromo-4,6-dimethyl-indoline |
| 09/26/2001 | EP1136099A1 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors |
| 09/26/2001 | EP1136071A2 Use of glycogen phosphorylase inhibitors |
| 09/26/2001 | EP1135386A1 Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives |
| 09/26/2001 | EP1135371A1 Beta-alanine derivatives as alpha 4 integrin inhibitors |
| 09/26/2001 | EP1135370A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 09/26/2001 | EP1135131A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 09/26/2001 | EP1031570A4 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency |
| 09/26/2001 | EP0900214B1 Process for preparation of pyrimidine derivatives |
| 09/26/2001 | EP0802922B1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds |
| 09/26/2001 | EP0773932B1 Benzenesulfonamide derivatives used as bradykinine antagonists |
| 09/26/2001 | CN1314912A Tartrate salt of a sabstituted dipentide as growth hormone secretagogue |
| 09/26/2001 | CN1314905A Muscarinic antagonists |
| 09/26/2001 | CN1314904A Alkynyl-substituted quinoline-2-one derivatives useful as anticancer agents |
| 09/26/2001 | CN1314891A Synthesis of benzo (F) quinolinones |
| 09/26/2001 | CN1314888A Crystalline forms of osanetant |
| 09/26/2001 | CN1314814A Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperdines)-butylazols in preparation of a medicament for the treamtent of pain |
| 09/26/2001 | CN1314355A Quinolone carboxylic acid derivatives or their salts |
| 09/26/2001 | CN1314346A Process for preparing radio-therapeutic sensitivity intensifier 2-substituted amino-3-cyano-5-nitropyridine |
| 09/26/2001 | CN1314345A Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 09/26/2001 | CN1071757C Pyrazol benzoyl derivatives |
| 09/26/2001 | CN1071753C 7-azabicyclo [2,2,1]-heptane and heptene derivatives as cholinergic receptor ligands |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294566 Imidazoline derivatives and uses thereof |
| 09/25/2001 | US6294565 Treatment of leukemia by administering a bisimidazole thiophene |
| 09/25/2001 | US6294558 Antiinflammatory agents and prostaglantins |
| 09/25/2001 | US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294554 Muscarinic antagonists |
| 09/25/2001 | US6294552 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/25/2001 | US6294536 Triazine derivatives, their production and use |
| 09/25/2001 | US6294533 Calcium channel blockers |
| 09/25/2001 | US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 09/25/2001 | CA2029132C Sulphonylaminocarbonyltriazolinones having substituents which are bonded via sulphur |
| 09/22/2001 | CA2341344A1 Use of glycogen phosphorylase inhibitors |